1. Home
  2. ASMB vs KOPN Comparison

ASMB vs KOPN Comparison

Compare ASMB & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

N/A

Current Price

$32.87

Market Cap

512.1M

Sector

Health Care

ML Signal

N/A

Logo Kopin Corporation

KOPN

Kopin Corporation

N/A

Current Price

$4.22

Market Cap

396.8M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ASMB
KOPN
Founded
2005
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
512.1M
396.8M
IPO Year
2010
2025

Fundamental Metrics

Financial Performance
Metric
ASMB
KOPN
Price
$32.87
$4.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$44.20
$4.69
AVG Volume (30 Days)
296.0K
4.0M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
91.78
103.03
EPS
N/A
N/A
Revenue
N/A
$1,530,311.00
Revenue This Year
N/A
$50.07
Revenue Next Year
$638.39
$33.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
46.53
52 Week Low
$20.23
$1.81
52 Week High
$39.71
$6.61

Technical Indicators

Market Signals
Indicator
ASMB
KOPN
Relative Strength Index (RSI) 51.54 45.33
Support Level $32.57 $4.20
Resistance Level $34.69 $4.52
Average True Range (ATR) 1.64 0.24
MACD -0.23 -0.08
Stochastic Oscillator 2.98 8.59

Price Performance

Historical Comparison
ASMB
KOPN

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: